Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 7, 2014, Pages 730-738

  Kurashina, Tomoyuki ^a   Nagasaka, Shoichiro ^a   Watanabe, Naoya ^b   Yabe, Daisuke ^c   Sugi, Noriko ^d   Nin, Kazuko ^e   Hosokawa, Masaya ^f   Nomura, Yoshio ^g   Fukushima, Mitsuo ^h   Nakai, Yoshikatsu ⁱ   Nishimura, Fusanori ^j   Taniguchi, Ataru ^k  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^c KANSAI ELECTRIC POWER CO   (Japan)

^d RAKUWAKAI OTOWA HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f Tezukayama Gakuin University   (Japan)

^g KOBE TOKIWA UNIVERSITY   (Japan)

^h OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

ⁱ Kyoto Institute of Health Science   (Japan)

^j KYUSHU UNIVERSITY   (Japan)

^k Kyoto Preventive Medical Center   (Japan)

more..

Author keywords

Glomerular filtration rate; Tumor necrosis factor receptors; Tumor necrosis factor

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; BLOOD; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905197531     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.21055     Document Type: Article

References (35)

1. Fujibayashi K, Fukuda H, Yokokawa H, Haniu T, Oka F, Ooike M, Gunji T, Sasabe N, Okumura M, Iijima K, Hisaoka T, Isonuma H: Associations between healthy lifestyle behaviors and proteiuria and the estimated glomerular filtration rate (eGFR). J Atherscler Thromb, 2012; 19: 932-940
2. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Rosan B, Warram JH, Krolewski AS: Serum concentrations of markers of TNF- α and Fasmediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol, 2009; 4: 62-70
3. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS: 926 Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol, 2012; 23: 516-524
4. Ng DP, Fukushima M, Tai BC, Koh D, Leong H, Imura H, Lim XL: Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-α system. Diabetologia, 2008; 51: 2318-2324
5. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol, 2012; 23: 507-515
6. Izumi Y, Yabe D, Taniguchi A, Fukushima M, Nakai Y, Hosokawa M, Okumura T, Nin K, Matsumoto K, Nishimura F, Nagasaka S, Seino Y: Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes. Diab Res Clin Pract, 2013; 99: 145-150
7. Heimburger O, Stenvinkel P: Adipokines in chronic kidney disease-Fat tissue gives nephrologists a message. Peritoneal Dialysis Int, 2005; 25: 340-342
8. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol, 2004; 15: 3184-3191
9. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shilpak MG: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int, 2007; 71: 239-244
10. Keller C, Katz R, Cushman M, Fried LF, Shlipak M: Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrology, 2008; 9: 9
11. Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O'Donnell CJ, Kathiresan S, Meigs JB, Keaney Jr JF, Rong J, Benjamin EJ, Fox CS: Inflammation, kidney function and albumiuria in the Framingham Offspring cohort. Nephrol Dial Transplant, 2011; 26: 920-926
12. Pruijm M, Ponte B, Vollenweider P, Mooser V, Paccaud F, Waeber G, Marques-Vidal P, Burnier M, Mochud M: Not all inflammatory markers are linked to kidney function: results from a population-based study. Am J Nephrol, 2012; 35: 288-294
13. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Journal of Diabetes Invest, 2010; 1: 212-228
14. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetology International, 2010; 1: 2-20
15. Taniguchi A, Nagasaka S, Fukushima M, Sakai M, Okumura T, Yoshii S, Watanabe T, Ogura M, Yamadori N, Nin K, Kuroe A, Yamada Y, Seino Y, Nakai Y: C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism, 2002; 51: 1578-1581
16. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism, 2003; 52: 1274-1278
17. Okumura T, Taniguchi A, Nagasaka S, Sakai M, Fukushima M, Kuroe A, Yoshii S, Nakamura T, Ogura M, Atarashi T, Nishida S, Nakai Y: Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients. Diabetes Metab, 2003; 29: 15-18
18. Taniguchi A, Fukushima M, Nakai Y, Ohgushi M, Kuroe A, Ohya M, Seino Y: Soluble tumor necrosis factor receptor 1 is strongly and independently associated with serum homocysteine in nonobese Japanese type 2 diabetic patients. Diabetes Care, 2006; 29: 949-950
19. Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y: Three measures of tumor necrosis factor α activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism, 2005; 54: 1297-1301
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419
21. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992
22. Japanese Society of Nephrology: Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012, Tokyo-Igakusha, Tokyo, 2012
23. Bertani T, Abbate M, Zoja C, Coma D, Perico N, Ghezzi P, Remuzzi G: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol, 1989; 134: 419-430
24. Karkar AM, Koshino Y, Cashman SJ, Dash AC, Bonnefoy J, Meager A, Rees AJ: Passive immunization against tumor necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol, 1992; 90: 312-318
25. Karkar AM, Smith J, Pusey CD: Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumor necrosis factor-alpha. Nephrol Dial Transplant, 2001; 16: 518-524
26. Navarro JF, Mora-Fernandez C: The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev, 2006; 17: 441-450
27. Navarro JF, Mora C, Gomets M, Muros M, Lopez-Aguilar C, Garcia J: Influence of renal involvement on peripheral blood mononuclear cell expression behavior of tumor necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Nephrol Dial Transplant, 2008; 23: 919-926
28. Smith CA, Farrah T, Goodwin RG: TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell, 1994; 76: 959-962
29. Murao K, Ohyama T, Imachi H: TNF-α stimulation of MCP-1 expression is mediated by the Akt/PKB signal transduction pathway in vascular endothelial cells. Biochem Biophys Res Commun, 2000; 276: 791-796
30. Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR: Tumor necrosis factor receptors: biology and therapeutic potential in kidney dieases. Am J Nephrol, 2012; 36: 261-270
31. Vielhauer V, Stavrakis G, Mayadas T: Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest, 2005; 115: 1199-1209
32. Kawasaki Y, Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Ohya M, Nagasaka S, Yamada Y, Inagaki N, Seino Y: Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm Metab Res, 2005; 37: 617-621
33. Bemelmans MH, Gouma DJ, Buurman WA: Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine, 1994; 6: 608-615
34. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl, 2013; 3: 1-150
35. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG: Chronic Kidney Disease Prognosis Consortium: associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet, 2012; 380: 1662-1673